Efficacy of twice-daily dosing of amoxycillin/clavulanate in acute otitis media in children.

Children with acute otitis media (AOM), aged 2-12 years, were randomised to 10 days treatment with amoxycillin/clavulanate (A/C) 70/10 mg/kg/day given b.i.d. (231 patients) or to A/C 60/15 mg/kg/day given t.i.d. (232 patients). Clinical success rates at end of therapy (10-17 days) were 91.8% for the b.i.d. group and 90.5% for the t.i.d. group and at follow-up (28-42 days) were 80.1% for the b.i.d. group and 77.6% for the t.i.d. group, indicating that the b.i.d. regimen was as effective as the t.i.d. regimen. There was no statistically significant difference in incidence of adverse experiences between the two groups. The overall incidence of protocol defined diarrhoea assessed from diary booklets was low, with a lower incidence in the b.i.d. group (6.7%) than in the t.i.d. group (10.3%). Significantly more patients in the b.i.d. group (83.1%) than in the t.i.d. group (72.8%) had at least 80% compliance over a 7-10 day treatment period. A/C given twice or three-times daily was highly effective in the treatment of AOM in children. The two regimens showed equivalent clinical efficacy, both were well tolerated, and there was evidence of improved compliance with the b.i.d. regimen.
AuthorsU Behre, H M Burow, P Quinn, F Cree, H E Harrison
JournalInfection (Infection) 1997 May-Jun Vol. 25 Issue 3 Pg. 163-6 ISSN: 0300-8126 [Print] GERMANY
PMID9181384 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Anti-Bacterial Agents
  • Clavulanic Acids
  • Penicillins
  • Clavulanic Acid
  • Amoxicillin
  • Acute Disease
  • Amoxicillin (administration & dosage, adverse effects)
  • Anti-Bacterial Agents (administration & dosage, adverse effects)
  • Child
  • Child, Preschool
  • Clavulanic Acid
  • Clavulanic Acids (administration & dosage, adverse effects)
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Drug Therapy, Combination (therapeutic use)
  • Female
  • Humans
  • Male
  • Otitis Media (drug therapy)
  • Penicillins (administration & dosage, adverse effects)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: